New
Empaa-M XR 12.5mg/1000mg Tablets (Empagliflozin + Metformin HCl)
Empaa-M XR 12.5mg/1000mg Tablets (Empagliflozin + Metformin HCl)
Empaa-M XR 12.5mg/1000mg Tablets (Empagliflozin + Metformin HCl)
Description
Empaa-M XR 12.5mg/1000mg Tablets (Empagliflozin + Metformin HCl)
Empaa-M XR 12.5mg/1000mg Tablets contain a fixed-dose combination of empagliflozin and extended-release metformin hydrochloride for the management of type 2 diabetes mellitus in adults. Empagliflozin lowers blood glucose by reducing renal glucose reabsorption, while metformin XR improves insulin sensitivity and decreases hepatic glucose production with prolonged release. This combination is prescribed under medical supervision for patients requiring dual-mechanism therapy and sustained glycemic control. Empaa-M XR is used in Pakistan as part of long-term diabetes management based on clinical assessment. Oxygen Pharmacy ensures authentic sourcing, appropriate storage, and nationwide availability.
